By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences' revenues for the second quarter rose 78 percent as grant revenues increased by 170 percent, the company disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Monday.

For the three months ended June 30, total revenues bounced to $661,000 from $371,000 a year ago. While product revenue dropped to $85,000 from $158,000 in Q2 2009, grant revenues shot up to $576,000 from $213,000 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.